Matteo Bonini

Dr. Matteo Bonini

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2019 in IEEE Transactions on Information Theory
Verified
Journal Article
Closed access
DBDaniele Bartoli
Daniele Bartoli
MBMatteo Bonini
Matteo Bonini

29 May 2023 in Expert Review of Clinical Immunology
Verified
Journal Article
Open access
JOJosje Otten
Josje Otten
RLRik van der Lans
Rik van der Lans
ECEugenio de Corso
Eugenio de Corso
KDKanstantsin Dziadziulia
Kanstantsin Dziadziulia
BHBart Hilvering
Bart Hilvering
WFWytske Fokkens
Wytske Fokkens
Type 2 targeting biologics have reached the market first for asthma and since 2019 also for CRSwNP. As clear guidelines and predictors for optimal biological choice are missing, patients are sometimes required to switch biologic therapy in order to find the optimal treatment result. In this paper, we evaluate reasons for switching biologics and the treatment effects after each sequential switch. Ninety-four patients who switched from one biologic to another for their treatment of CRSwNP and asthma were evaluated. Twenty patients experienced satisfactory control of CRSwNP, but insufficient control of severe asthma. Fifty-one patients experienced satisfactory control of severe asthma, but insufficient control of CRSwNP/EOM. Twenty-eight patients experienced insufficient control of both upper and lower airways. Thirteen patients had to switch because of side effects. Furthermore, two cases are described to clarify clinical decision-making. For abovementioned patients, a multidisciplinary approach is mandatory to find the best suitable biologic. It seems ineffective to switch to a second anti-IL5 treatment if the first one is not successful. Most patients that failed omalizumab and/or an anti-IL-5 treatment are well controlled on dupilumab. Therefore, we suggest to use dupilumab as first choice when switching biologic agents.

27 February 2021 in Cryptography and Communications
Verified
Journal Article
Closed access
PDF file
DBDaniele Bartoli
Daniele Bartoli
MBMatteo Bonini
Matteo Bonini
BGBurçin Güneş
Burçin Güneş

1 September 2021 in Journal of Asthma
Verified
Journal Article
Open access
FBFulvio Braido
Fulvio Braido
Francesco BlasiFrancesco Blasi
Francesco Blasi
Giorgio Walter CanonicaGiorgio Walter Canonica
Giorgio Walter Canonica
PPPierluigi Paggiaro
Pierluigi Paggiaro
Bianca BeghèBianca Beghè
Bianca Beghè
MYMona-Rita Yacoub
Mona-Rita Yacoub
The prevalence of asthma in Italy is estimated to be around 4%; it affects approximately 2,000,000 citizens, and up to 80–90% of patients have mild-to-moderate asthma. Despite the clinical relevanc...

20 July 2018 in Advances in Geometry
Verified
Journal Article
Closed access
PDF file
MBMatteo Bonini
Matteo Bonini
MMMaria Montanucci
Maria Montanucci
GZGiovanni Zini
Giovanni Zini
Let 𝓒 be a plane curve defined over the algebraic closure K of a finite prime field 𝔽p by a separated polynomial, that is 𝓒 : A(Y) = B(X), where A(Y) is an additive polynomial of degree pn and the degree m of B(X) is coprime with p. Plane curves given by separated polynomials are widely studied; however, their automorphism groups are not completely determined. In this paper we compute the full automorphism group of 𝓒 when m ≢ 1 mod pn and B(X) = Xm. Moreover, some sufficient conditions for the automorphism group of 𝓒 to imply that B(X) = Xm are provided. Also, the full automorphism group of the norm-trace curve 𝓒 : X(qr – 1)/(q–1) = Yqr–1 + Yqr–2 + … + Y is computed. Finally, these results are used to show that certain one-point AG codes have many automorphisms.

16 August 2018 in Designs, Codes and Cryptography
Verified
Journal Article
Closed access
PDF file
DBDaniele Bartoli
Daniele Bartoli
MBMatteo Bonini
Matteo Bonini